Searched for
MEDA PHARMA
US Pfizer deal powers European health stocks as Trump policy haze clearsEuropean healthcare stocks jumped on Wednesday, mirroring moves in the United States, propelled by a deal between Pfizer and President Dona...- For Glenn Saldanha, innovation is the new Vitamin for Glenmark's successInvestors complained, competitors were mystified and Saldanha's father was skeptical. Nevertheless, Saldanha pressed ahead in the painstaki...
- Cipla bets on speciality drugs in US; aims for commercial launch by 2020The company plans to deploy more funds for research and development in various segments and hopes for the first commercial launch in the US...
- Brokerages upgrade Cipla after strong Q1 resultsBrokerages have raised their EPS estimates and target price on the stock on the back of rupee depreciation and Medpro acquisition.
- Sensex tanks 100 points; top eleven stocks in actionThe Sensex dropped over 100 points in mid-morning trade, led by losses in ITC, HDFC Bank, Infosys and RIL.
- Any dip in Sun Pharma is a buying opportunity: Anish Damania"The earnings trajectory for Sun Pharma looks good. So any dip is a buying opportunity. "
- Meda AB denies acquisition talks with Sun PharmaSwedish drug firm Meda AB, denies reports of being in discussions with Sun Pharmaceutical Industries for a $ 5 billion stake sale
- Eleven stocks in focus in Thursday morning tradeIndian markets are likely to trade in a range. Here is a list of eleven stocks which are likely to remain in focus in morning trade.
- Swedish company Meda expands collaboration with CiplaMeda pharma said that the company is broadening its collaboration with Cipla, expanding its exclusive rights to Dymista and future product ...
- Expect markets to stabilise & move higher over next 2 months: Sandip Sabharwal, Prabhudas LilladherGiven the way the inflation trajectory is expected to continue to remain low, we should see the markets stabilise and move higher over the ...
- Sun Pharma slips 2% on reported plans to buy Sweden's MedaSun Pharma shares lost ground on worries that a potential acquisition would reduce Sun Pharma’s cash position and increase debt.
- Fifteen stocks in focus in Monday morning tradeThe BSE Sensex pared all its early morning gains and turned negative on Monday, led by losses in ITC, Reliance Industries and Tata Motors.
- Sun Pharma in talks to buy Sweden's Meda AB for up to $5 billion: ReportsSun Pharmaceutical Industries is said to be in talks to buy Sweden's pharma firm Meda AB in a deal worth up to $5 billion, according to med...
- Cipla PAT seen up 21% led by higher other income and lower tax rate: ET NOW PollCipla is expected to report a 21 per cent jump in its net profit for the quarter ended September 30 to Rs 373 crore from Rs 309 crore repor...
- Brokerages raise Cipla’s target after robust resultsPositive changes in the business model by the new management and increasing utilization of the Indore SEZ are key positives.
- Ex-Teva Frank Pieters to lead Cipla's European respiratory businessCipla, India's second-largest drug maker, has hired Teva's former vice-president Frank Pieters to spearhead its European respiratory busine...
Load More
